CIDARA THERAPEUTICS INC (CDTX)

US1717571079 - Common Stock

0.7799  -0.04 (-5.43%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to CDTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.36. This target is 586.63% above the current price.
CDTX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CDTX.
In the previous month the buy percentage consensus was at a similar level.
CDTX was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.783.035.615.367.35 - 288.51% 619.32% 586.63% 842.43%
Up and Down Grades
Date Firm Action Rating
2024-04-08 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-07 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-06 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-22 Needham Reiterate Buy -> Buy
2023-09-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-08 Needham Reiterate Buy -> Buy
2023-09-07 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-07 HC Wainwright & Co. Reiterate Buy
2023-08-04 Needham Reiterate Buy -> Buy
2023-08-01 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-01 HC Wainwright & Co. Reiterate Buy
2023-06-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-12 Needham Reiterate Buy -> Buy
2023-04-18 Needham Reiterate Buy
2023-03-24 HC Wainwright & Co. Reiterate Buy
2023-03-23 HC Wainwright & Co. Maintains Buy
2023-03-08 Cantor Fitzgerald Reiterate Overweight
2023-03-01 HC Wainwright & Co. Reiterate Buy
2023-01-25 HC Wainwright & Co. Maintains Buy
2022-05-12 HC Wainwright & Co. Maintains Buy
2021-09-22 WBB Securities Upgrade Buy -> Strong Buy
2021-09-22 Aegis Capital Maintains Buy
2021-03-04 Aegis Capital Initiate Buy